Drugmakers to share neglected compounds with British academia
24 July 2014
A group of seven leading drugmakers has agreed to share an array of neglected experimental medicines with British academic researchers in the latest example of the deepening ties between industry and external scientists.
22 July 2014
What began as a trickle of companies seeking to take advantage of lower corporate tax rates overseas is beginning to look more like a fully fledged stampede for the exit as at least eight US-based companies have announced plans this year for deals that would involve reincorporating abroad.
Drive to Add FDA Drug Police in India Delayed
22 July 2014
Five months after the top U.S. drug regulator promised to expand the office that polices Indian companies that make medicine for U.S. patients, an exodus of workers is cramping the effort.
NIH scientists identify gene linked to fatal inflammatory disease in children
17 July 2014
Repurposed drugs may offer first potential therapy
Overcoming Clinical Challenges in Russia
17 July 2014
Slated to rise from 11th to eighth place in the global pharmaceutical rankings, Russia is steadily proving to be a lucrative market for investors. With increased healthcare expenditure and governmental support of innovation through the implementation of Strategy 2020, policymaking and industry reform are shaping Russia’s drug development landscape. Efforts to localize pharmaceutical manufacturing and increase domestic R&D standing have been successful.
17 July 2014
Since 2012, a 15% preferential contract price has been granted to domestic producers bidding in government tenders. Currently, there are plans to increase this preferential pricing by up to 40% of the total contract price.
EMA Recommends 39 Drugs in First Half of 2014
16 July 2014
Thirty-nine drugs were recommended for marketing authorization by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared with 44 in first half of 2013 and 33 in first half of 2012. The recommended drugs included drugs designed to fill unmet medical needs, treat diseases for which no treatments were previously available, or bring significant added benefit to patients over existing therapies.
Russian start-up launches web-based cancer diagnosis service
16 July 2014
Russian start-up Unim (United Medicine) has launched the Unim Histology Internet service, which will make it possible for cancer patients to send analyses remotely to the Dmitri Rogachev Federal Clinical and Research Center for Pediatric Hematology, Oncology, and Immunology in Moscow, reported East-West Digital News, the first all English-language online resource dedicated to Russian digital industries.
Solid technology, smart decisions at the heart of Regeneron's remarkable R&D productivity
16 July 2014
Regeneron Pharmaceuticals has emerged as one of the most prolific wellsprings of new antibody drugs in the biopharma universe thanks to its success in combining innovative technologies with intelligent target selection.
Russian patients will be available to innovative treatments for skin cancer
15 July 2014
In recent years, the world is rapidly increasing incidence of cancer including skin cancer, which accounted for Russia in the structure of malignant tumors account for 10.7% and each year this figure grows by 2-3%. This arises primarily environmental degradation and the harmful effects of ultraviolet radiation from the sun, having a carcinogenic effect.
Merry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
2024 drug approvals: Small companies loom large with several key FDA nods
13 January 2025
Special Regulations for Foreign-Packaged Medicines Extended Until the End of 2025
13 January 2025
Russia Begins Production of Terbium-161 Isotope for Cancer Therapy
10 January 2025
FMBA has begun clinical trials of a vaccine against five serotypes of meningococcus
10 January 2025